As compared to PI3K/AKT upstream, downstream effector genes are regulated more obviously with m6A modifications, for example, Foxo1, G6pc, Fasn mRNA upregulation in the liver of T2D patients (77), leading to increased glycemia and hepatic steatosis (106). The gene discussed is AKT1; the disease is type 2 diabetes mellitus.